Sources | Names Used |
---|---|
CTRPv2 | cyanoquinoline 11 |
PharmacoGx | cyanoquinoline 11 |
Database | Identifier |
---|---|
Smiles: | Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cnc[nH]4)cc23)C#N)cc1Cl |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LINC00633 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | UBP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | SSH2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | PAXIP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | PLOD2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
mRNA | DIEXF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | PLD3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | CCL15-CCL14 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | URB2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | CD99 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |